Articles

State laws capping patients’ out-of-pocket insulin costs, though well-intentioned, have had limited impact.

Publicly insured individuals who are most likely to benefit from new diabetes and obesity drugs are less likely to get them than those with private insurance.

As policymakers consider reforms to the prescription drug supply chain, they should keep five principles in mind to ensure better outcomes for patients.

Schaeffer Center experts provided comments to CMS on issues with how Coverage with Evidence Determination policy is applied.

The University of Southern California (USC) announces an opening for a fellow to join the Alzheimer’s Trial Recruitment Innovation Lab (ATRIL) fellowship program in the fall of 2024.

Climate change, health and food insecurity will be major focuses of a new initiative aimed at creating policies and communication that better fit people’s needs.

Most people see hospital-level care provided in a patient’s home as convenient, comfortable and effective.

Why many of the key assertions in a recent Forefront article challenging the MedPAC’s estimate that favorable selection and upcoding increase payments to Medicare Advantage (MA) plans in 2024 by $83 billion are wrong

Knowing the actual costs of dementia could help families plan their budgets and support needs, inform treatment and caregiving options, and shape health care policy.

The findings suggest that the Supreme Court’s reversal of Roe v Wade has had wider ramifications for women’s reproductive health than previously thought.